What are the limitations and challenges of pursuing a career outside the traditional career path? How can physicians broaden their conception of what impact really means? In this episode, we answer all these questions and more with our guest, Bobak Azamian, MD.
Bobak is President and CEO of Tarsus Pharmaceuticals, a public biotech company, which revolutionizes therapeutics for essential diseases in eye care, dermatology, and infectious diseases.
Bobak completed an MD from Harvard Medical School (Harvard-MIT Health Sciences and Technology), a PhD in Chemistry from Oxford University as a Rhodes Scholar, and a BA in Physics from Rice University.
How do you take that first step and balance clinical duties with non-clinical interests? What specific advances in biotech could have the potential to...
How to venture early off the beaten path? How to gain multiple skills and still focus on investments in healthcare and life sciences from...
How can MDs interested in venture capital and entrepreneurship break into a very network-driven industry? How can being a doctor in the VC world...